Feed aggregator

Merck Challenges AstraZeneca, Sanofi With Phase IIb/III Data for RSV Antibody

Biospace news - Tue, 07/23/2024 - 02:00

Agilent Pays $925M to Buy CDMO Biovectra to Boost Biologics, CRISPR Capabilities

Biospace news - Tue, 07/23/2024 - 02:00

SEC Hits Allarity With Wells Notice, Flags Alleged Violations in FDA Meeting

Biospace news - Tue, 07/23/2024 - 02:00

HHS Issues Negative Opinion on Bluebird’s Fertility Support Program for Gene Therapies

Biospace news - Tue, 07/23/2024 - 02:00

Samsung Bioepis Gets FDA Approval for Biosimilar to AstraZeneca’s Soliris

Biospace news - Mon, 07/22/2024 - 02:00

Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval

Biospace news - Mon, 07/22/2024 - 02:00

Lilly Wins Chinese Approval for Tirzepatide in Obesity on Heels of Novo’s Semaglutide

Biospace news - Mon, 07/22/2024 - 02:00

GSK Plots Blenrep’s Path Back to Market With EU Filing

Biospace news - Mon, 07/22/2024 - 02:00

SIGA, US Government Ink $113M Procurement Deal for Smallpox, Mpox Drug

Biospace news - Mon, 07/22/2024 - 02:00

Career Support, Development Trump Pay, According to Recent Reports

Biospace news - Mon, 07/22/2024 - 02:00

2024 Job Search Toolkit

Biospace news - Fri, 07/19/2024 - 02:00
BioSpace has updated our Job Search Toolkit, including recent resources to help you succeed with your next job search.

George Church Startup Nets $60M to Take Non-Standard Amino Acids to the Clinic

Biospace news - Fri, 07/19/2024 - 02:00

Boehringer Ingelheim Partners With GoodRx to Offer Humira Biosimilar at 92% Discount

Biospace news - Fri, 07/19/2024 - 02:00

AVEO’s Fotivda Combo Flunks Phase III Renal Cell Carcinoma Study

Biospace news - Fri, 07/19/2024 - 02:00

Updated: Artiva’s IPO Jumps to $167M

Biospace news - Fri, 07/19/2024 - 02:00

Phathom Scores Non-Erosive GERD Approval for Heartburn Drug

Biospace news - Thu, 07/18/2024 - 02:00

Despite Layoff Announcements, Novartis Beats Q2 Expectations

Biospace news - Thu, 07/18/2024 - 02:00

Who Is Driving The Bus - Drug Developers & Healthcare Providers or AI?

Biospace news - Thu, 07/18/2024 - 02:00

Future of Agenus’ Immunotherapy Combo Uncertain as FDA Discourages Accelerated Approval in CRC

Biospace news - Thu, 07/18/2024 - 02:00

Touting Shockwave’s Billion-Dollar Potential, J&J Lifts 2024 Guidance

Biospace news - Thu, 07/18/2024 - 02:00